Both caveolin-1 and PPARγ are present at low levels in monocytes from SSc patients and healthy AA that exhibit an enhanced ability to differentiate into fibrocytes/myofibroblasts (Reese et al., 2014b) and an inhibited ability to differentiate into adipocytes (Figure 1). This evidence concerns the gene CAV1 and systemic sclerosis.